Skip to content

The usage survey of phosphate binder for CKD-MBD in western Saitama hemodialysis facilities.

The usage survey of phosphate binder for CKD-MBD in western Saitama hemodialysis facilities. - The usage survey of phosphate binder for CKD-MBD in western Saitama hemodialysis facilities.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022935
Enrollment
3600
Registered
2016-07-01
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD-MBD in hemodialysis patients

Interventions

None listed

Sponsors

Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All cases investigation

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

MeasureTime frame
The achievement rate of serum phosphate value.

Countries

Japan

Contacts

Public ContactHiroaki Amano

Saitama Medical University Department of Nephrology

hiama@saitama-med.ac.jp049-276-1611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026